Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost topical solution vs vehicle and minoxidil in men with androgenic alopecia
2011-000379-15Phase 2Completed
- Sponsor
- Allergan
- Start
- Apr 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bimatoprost in androgenetic alopecia (AGA) (5 arms), sponsored by Allergan. Primary endpoint: Target Area Hair Count. Started Apr 2011; status: completed.
02
Drugs
bimatoprost
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on 2011-000379-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000379-15.